NCT00004375Unknown2 期
Ultraviolet Light Therapy for Systemic Lupus Erythematosus
National Center for Research Resources (NCRR)4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 1991年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 20
- 试验地点
- 4
研究概览
简要总结
OBJECTIVES:
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
详细描述
PROTOCOL OUTLINE:
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 15 Years 至 70 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •PROTOCOL ENTRY CRITERIA:
- •-Disease Characteristics--
- •Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls
- •-Prior/Concurrent Therapy--
- •No requirement for tetracycline or other photosensitizing drugs
排除标准
- 未提供
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Low-dose UVA1 Radiation in Cutaneous Lupus PatientsCutaneous Lupus ErythematosusNCT01776190Ben Chong6
已完成
不适用
UVA1 Phototherapy in Acral VitiligoAcral VitiligoNCT03378011Cairo University20
招募中
不适用
Bright light therapy in rheumatoid arthritis to improve symptoms of fatigue and other disease outcomes.Rheumatoid arthritisNL-OMON22327eiden University48
终止
1 期
Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3Cervical CancerNCT00005808National Cancer Institute (NCI)54
已完成
不适用
ltraviolet Light (UV) Therapy for Atopic Dermatitis: Double blind, randomised trial of narrow band (TLO1) versus UVA versus placebo.Skin and connective tissue diseases:Skin and Connective Tissue DiseasesAtopic DermatitisISRCTN10725589HS R&D Regional Programme Register - Department of Health (UK)75